Outpatient Treatment of Alcohol Withdrawal Syndrome
Completed
Hvidovre University Hospital
Phase 3
2003-08-01
The purpose of this study is to compare a fixed-schedule therapy versus a symptom-triggered
therapy for alcohol withdrawal syndrome in medical outpatients.
Objectives:
- Self-governance in monitoring AWS (alcohol withdrawal syndrome) symptoms and medication
- Clinically controlled trial of two regimens for medical treatment of alcohol withdrawal
syndrome
- Outpatient treatment of alcohol withdrawal syndrome
Placebo Controlled Trial of Depakote ER in Alcohol Dependent Patients With Mood and/or Anxiety Symptoms
Completed
Abbott
Phase 2/Phase 3
2004-09-01
The purpose of this study is to test the safety and effectiveness of an extended release form
of a medication called divalproex sodium (Depakote ER) for the treatment of people with
alcohol dependence who have mood and/or anxiety symptoms. This medication has helped reduce
symptoms of acute alcohol withdrawal as well as stabilize mood symptoms in bipolar disorder
and other mental health disorders. This study will test the hypothesis that divalproex sodium
will help reduce mood and anxiety symptoms during early abstinence from alcohol and in turn
reduce relapse and craving for alcohol.
Placebo Controlled Trial of Depakote ER in Alcohol Dependent Patients With Mood and/or Anxiety Symptoms
Completed
Seattle Institute for Biomedical and Clinical Research
Phase 2/Phase 3
2004-09-01
The purpose of this study is to test the safety and effectiveness of an extended release form
of a medication called divalproex sodium (Depakote ER) for the treatment of people with
alcohol dependence who have mood and/or anxiety symptoms. This medication has helped reduce
symptoms of acute alcohol withdrawal as well as stabilize mood symptoms in bipolar disorder
and other mental health disorders. This study will test the hypothesis that divalproex sodium
will help reduce mood and anxiety symptoms during early abstinence from alcohol and in turn
reduce relapse and craving for alcohol.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
